|
Oct 16
|
Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Adults with Increased Risk for Pneumococcal Disease
|
|
Oct 15
|
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
|
|
Oct 15
|
Merck (MRK) Rises As Market Takes a Dip: Key Facts
|
|
Oct 15
|
Exelixis, MRK Collaborate for Combination Studies on HNSCC and RCC
|
|
Oct 14
|
erck & Co. (MRK): Winrevair Approval Drives Cardiovascular Growth
|
|
Oct 14
|
Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination with KEYTRUDA® (pembrolizumab) in Head and Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell Carcinoma
|
|
Oct 12
|
Is Merck & Co. Inc. (MRK) The Most Undervalued Quality Stock To Buy According To Analysts?
|
|
Oct 11
|
Does Merck (NYSE:MRK) Have A Healthy Balance Sheet?
|
|
Oct 11
|
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Oct 11
|
Should You Invest in Merck & Co. (MRK)?
|
|
Oct 10
|
Is Merck & Co Inc. (MRK) the Best Quality Stock to Buy According to Analysts?
|
|
Oct 9
|
MSD ventures into fibroblast therapies with $1.9bn deal with Mestag
|
|
Oct 9
|
New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio
|
|
Oct 9
|
MSD’s Phase III trial of head and neck cancer treatment meets primary endpoint
|
|
Jul 28
|
Merck & Co., Inc.'s (NYSE:MRK) Dismal Stock Performance Reflects Weak Fundamentals
|
|
Jul 26
|
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
|
|
Jul 24
|
MSD reports positive topline data from Phase IIb/III RSV trial in infants
|
|
Jul 23
|
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
|
|
Jul 23
|
Merck Announces Fourth-Quarter 2024 Dividend
|
|
Jul 23
|
Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?
|